Rosacea is treated with a composition comprising an antimicrobial and at
least one of an anti-inflammatory and a non-retinoid inhibitor of at
least one of NF-.kappa..beta., AP-1, MMPs, adhesion molecules, TLRs, and
CD14. The composition may further comprise a retinoid.